Immunic, Inc. (IMUX) Earnings History
Net Loss15 years of earnings data (2011–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Immunic, Inc. (IMUX) Earnings Overview
As of June 12, 2026, Immunic, Inc. (IMUX) reported trailing twelve-month net income of -$104M, reflecting +37.6% year-over-year growth. The company earned $-3.46 per diluted share over the past four quarters.
Looking at the long-term picture, IMUX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2011.
Immunic, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ARQT (-$2M net income, -4.3% margin), VNDA (-$240M net income, -102.0% margin), PRAX (-$327M net income), IMUX has comparable earnings metrics. Compare IMUX vs ARQT →
IMUX Earnings vs Peers
Earnings metrics vs comparable public companies
IMUX Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$97M | +3.3% | -$103M | $-6.24 | - | - |
| 2024 | -$101M | -7.4% | -$98M | $-10.00 | - | - |
| 2023 | -$94M | +22.3% | -$99M | $-21.10 | - | - |
| 2022 | -$120M | -29.5% | -$119M | $-37.80 | - | - |
| 2021 | -$93M | -111.2% | -$92M | $-39.20 | - | - |
| 2020 | -$44M | -26.4% | -$49M | $-28.10 | - | - |
| 2019 | -$35M | +16.0% | -$37M | $-45.10 | - | - |
| 2018 | -$41M | +20.4% | -$42M | $-391.60 | - | - |
| 2017 | -$52M | -27.1% | -$53M | $-522.60 | - | - |
| 2016 | -$41M | +21.2% | -$41M | $-522.10 | -648756.9% | -653460.0% |
| 2015 | -$52M | -9.1% | -$52M | $-827.30 | - | - |
| 2014 | -$48M | -45.7% | -$50M | $-800.10 | - | - |
| 2013 | -$33M | -388.3% | -$31M | $-23197.70 | - | - |
| 2012 | -$7M | -14.0% | -$10M | $-4751.10 | - | - |
| 2011 | -$6M | - | -$9M | $-4168.30 | - | - |
Download Data
Export IMUX earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in IMUX back in 2011?
Total return with dividends reinvested · 15+ years of data
Calculate ReturnsHow much would $100/month in IMUX be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs IMUX Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationIMUX vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowIMUX — Frequently Asked Questions
Quick answers to the most common questions about buying IMUX stock.
What is IMUX earnings per share (EPS)?
IMUX trailing twelve-month (TTM) diluted EPS is $-3.46, reflecting +37.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2011 to 2025 is available in the table on this page.
What is Immunic, Inc.'s net income?
Immunic, Inc. (IMUX) trailing twelve-month net income is $-104M as of 2025. Earnings grew +37.6% year-over-year.
Is IMUX profitable?
IMUX is not currently profitable on a TTM basis, reporting a net loss of $-104M. Net margin is N/A. Investors should monitor for a return to profitability.
What is IMUX's earnings growth rate?
IMUX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2011 to 2025.
What are IMUX's profit margins?
Immunic, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -1653.1%.
Is IMUX growing earnings?
Yes, IMUX earnings are accelerating — EPS growth of +37.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-104M. Earnings momentum is strengthening.
What was IMUX's best earnings year?
Immunic, Inc.'s highest annual net income on record is $-6M, achieved in fiscal year 2011. Earnings history on this page spans 2011 to 2025 and includes all annual and quarterly figures.
What were IMUX's earnings last quarter?
IMUX's most recent reported quarter was Q1 2026. Net income was $-33M with diluted EPS of $-1.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.